Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,988,940
-
Share change
-
+6,407,734
-
Total reported value
-
$740,571,244
-
Price per share
-
$37.05
-
Number of holders
-
94
-
Value change
-
+$237,681,001
-
Number of buys
-
79
-
Number of sells
-
15
Institutional Holders of G1 THERAPEUTICS INC - COM (GTHX) as of Q1 2018
As of 31 Mar 2018,
G1 THERAPEUTICS INC - COM (GTHX) was held by
94 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,988,940 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, FRANKLIN RESOURCES INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Cormorant Asset Management, LP, EMERALD ADVISERS INC/PA, Hillhouse Capital Management, Ltd., and Boxer Capital, LLC.
This page lists
94
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.